SENSEX 77414.92 ▼ (0.25%)
BSE BANKEX 59542.38 ▲ (0.36%)

PIRAMAL PHARMA

BSE: 543635 22 Aug 2025
Healthcare
₹ 192.8
PIRAMAL PHARMA LIMITED specializes in Pharmaceuticals within the Healthcare sector.

PIRAMAL PHARMA - Share Price & Details

Market Cap
₹25,528
High /Low
308.0 / 180.0
Stock P/E
296.0
Book Value
₹61.3
Dividend Yield
0.07
ROCE
6.45
ROE
₹1.11
Face Value
10.0
PEG Ratio
-7.66
EVEBITDA
₹18.8
Debt
4,856
CMP / FCF
1,159
Debt to equity
₹0.6
NP Ann
91.1
High price all time
308.0
Piotroski score
₹7.0
Graham Number
32.0
No. Eq. Shares
133.0
Net CF
₹-36.9
Net profit
98.1
Price to book value
3.13
Interest Coverage
₹1.9
Low price all time
61.6
Industry PE
32.8
Reserves
₹6,801
Free Cash Flow
₹233

Price Chart


Volume Chart


Peer Comparison

Stock Total Income Net Profit Net Sales EPS Market Cap (in Cr) P/E
Shyama Computronics and Servic1.480.930.670.005.3335.5
Triochem Products Ltd.,3.25-4.52NA-18.440
PIRAMAL PHARMA LIMITED11508.01131.49698.80.8525,528296.0
Eris Lifesciences Limited6013.2999.95786.47.332385861.6
WOCKHARDT LTD.4380.0690.04130.04.2523826467.0

Peer Comparison Chart


About PIRAMAL PHARMA

PIRAMAL PHARMA LIMITED, with Security Code 543635, is a leading player in the Pharmaceuticals industry, categorized under the Healthcare sector, offering Equity instruments.


Latest News

Vishal Bhargava Appointed as Chief Information Officer at Piramal Pharma Ltd - Consumer Products Division

(13 Aug 2025)
Piramal Pharma Ltd – Consumer Products Division has announced the appointment of Vishal Bhargava as its new Chief Information Officer (CIO),...
Read more →

Piramal Pharma Limited (PPLPHARMA) Stock Experiences Sudden Dip - Rapid growth opportunities

(06 Aug 2025)
Piramal Pharma Limited (PPLPHARMA) Stock Experiences Sudden Dip ✌️【Stock Trends】✌️ Gain instant access to under-the-radar stocks with high...
Read more →

Piramal Pharma's loss narrows to Rs82 crore in June quarter

(30 Jul 2025)
Piramal Pharma Ltd plans to increase capacities for its contract development and manufacturing business, says chairperson Nandini Piramal.
Read more →

Piramal Pharma Limited Announces Results for Q1FY26

(30 Jul 2025)
Share this article ... MUMBAI, India, July 28, 2025 /PRNewswire/ -- Piramal Pharma Limited (NSE: PPLPHARMA) (BSE: 543635), a leading global...
Read more →

US CDMO business seeing softening, says Piramal Pharma Chairperson

(30 Jul 2025)
Piramal Pharma: US biotech funding slowdown hits Piramal's CDMO business as company expands sterile injectables facility and maintains...
Read more →

Would You Accumulate or Wait on Piramal Pharma Limited (PPLPHARMA) - Breakthrough profit margins

(23 Jul 2025)
【Market Focus】✌️ Our platform specializes in identifying explosive growth stocks with a proven record of exceeding 200% ROI for savvy...
Read more →

Company Updates